Chrysanthemum Morifolium, traditionally known for its cooling properties in East Asian medicine, has evolved into a multi-billion dollar industrial raw material. Today, it serves as a critical source for Luteolin, Chlorogenic Acid, and various Flavonoids used in the global pharmaceutical and nutraceutical sectors. As search intent shifts from simple tea products to "High-Purity Active Ingredients," wholesale suppliers must bridge the gap between traditional cultivation and modern molecular extraction.
Utilized in anti-inflammatory drugs and ophthalmic support formulas. Requires strict USP/BP compliance for heavy metal limits and pesticide residues.
Water-soluble powders used in ready-to-drink (RTD) teas and wellness shots. Focus is on organoleptic consistency and solubility.
Incorporated into skincare for its soothing and UV-protection properties. High demand for eco-friendly extraction methods.
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts, and have accumulated rich industry experience.
Our commitment to E-E-A-T principles ensures that every batch of Chrysanthemum Morifolium extract meets the highest international safety standards.
By leveraging deep-rooted relationships with over 200 close-related suppliers, we ensure a stable harvest cycle regardless of climatic fluctuations.
Strategic positioning in Jiangxi allows for rapid transit to major ports, ensuring that biological products and plant extracts reach global destinations with minimal lead times.
Integration of manufacturing and export services reduces intermediate costs, allowing us to offer competitive pricing without compromising on GMP/USP quality.
Exploring the shift toward sustainable plant sources in global pharmacology.
Why Dexamethasone Sodium Phosphate API remains essential for healthcare infrastructure.
FDA approval of Eli Lilly's Foundayoâ„¢ marks a new era in weight-loss pharmacology, setting speed records for NME approval.
